Genocea Biosciences (GNCAQ) Competitors

GNCAQ vs. VECT, ATNFW, SXTPW, ACONW, AIMDW, DRTSW, ALVOW, AONCW, AONC, and APLMW

Should you be buying Genocea Biosciences stock or one of its competitors? The main competitors of Genocea Biosciences include VectivBio (VECT), 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Aclarion (ACONW), Ainos (AIMDW), Alpha Tau Medical (DRTSW), Alvotech (ALVOW), American Oncology Network (AONCW), American Oncology Network (AONC), and Apollomics (APLMW). These companies are all part of the "medical" sector.

Genocea Biosciences vs.

Genocea Biosciences (NASDAQ:GNCAQ) and VectivBio (NASDAQ:VECT) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, community ranking, risk, media sentiment, profitability, dividends, earnings and analyst recommendations.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Genocea Biosciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
VectivBio
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Genocea Biosciences has higher earnings, but lower revenue than VectivBio.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Genocea Biosciences$1.64MN/A-$33.20MN/AN/A
VectivBio$27.34MN/A-$93.74MN/AN/A

In the previous week, VectivBio had 3 more articles in the media than Genocea Biosciences. MarketBeat recorded 3 mentions for VectivBio and 0 mentions for Genocea Biosciences. VectivBio's average media sentiment score of 0.70 beat Genocea Biosciences' score of 0.00 indicating that VectivBio is being referred to more favorably in the news media.

Company Overall Sentiment
Genocea Biosciences Neutral
VectivBio Positive

Company Net Margins Return on Equity Return on Assets
Genocea BiosciencesN/A N/A N/A
VectivBio N/A N/A N/A

VectivBio received 10 more outperform votes than Genocea Biosciences when rated by MarketBeat users.

CompanyUnderperformOutperform
Genocea BiosciencesN/AN/A
VectivBioOutperform Votes
10
43.48%
Underperform Votes
13
56.52%

Summary

VectivBio beats Genocea Biosciences on 4 of the 5 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GNCAQ vs. The Competition

MetricGenocea BiosciencesBiological Products IndustryMedical SectorNASDAQ Exchange
Market CapN/A$2.98B$5.17B$7.97B
Dividend YieldN/A2.18%43.86%3.91%
P/E RatioN/A9.99111.5814.17
Price / SalesN/A329.482,362.1377.54
Price / CashN/A168.1636.3731.98
Price / BookN/A7.155.744.77
Net Income-$33.20M-$43.77M$105.38M$217.01M

Genocea Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VECT
VectivBio
0 of 5 stars
$16.85
flat
N/AN/A$0.00$27.34M0.00N/AHigh Trading Volume
ATNFW
180 Life Sciences
0 of 5 stars
$0.01
flat
N/A-58.0%$0.00N/A0.004News Coverage
Positive News
Gap Up
SXTPW
60 Degrees Pharmaceuticals
0 of 5 stars
$0.10
flat
N/AN/A$0.00$253,573.000.002Positive News
Gap Down
ACONW
Aclarion
0 of 5 stars
$0.04
-19.2%
N/AN/A$0.00$75,404.000.004Gap Down
AIMDW
Ainos
0 of 5 stars
$0.06
flat
N/A-81.8%$0.00$122,112.000.0046Gap Down
DRTSW
Alpha Tau Medical
0 of 5 stars
$0.24
flat
N/A-28.1%$0.00N/A0.00121Short Interest ↓
ALVOW
Alvotech
0 of 5 stars
$3.25
-0.6%
N/A+158.3%$0.00$91.43M0.00999
AONCW
American Oncology Network
0 of 5 stars
$0.20
-22.8%
N/AN/A$0.00$1.28B0.001,525Gap Down
High Trading Volume
AONC
American Oncology Network
0 of 5 stars
$3.71
-2.4%
N/AN/A$0.00$1.28B0.001,525Short Interest ↓
News Coverage
High Trading Volume
APLMW
Apollomics
0 of 5 stars
$0.03
flat
N/A-83.9%$0.00N/A0.0059

Related Companies and Tools

This page (NASDAQ:GNCAQ) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners